No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
240 |
4. Check minimum number of eventsNone |
240 |
5. Include endpointsNone |
240 |
6. Filter based on genotype QC (FinnGen only) |
219 |
Control definitions (FinnGen only)
- Control exclude
- E4_ENDOGLAND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF6
Similar endpoints
↥List of similar endpoints to
Precocious central puberty
based on the number of shared cases.
Similar with more cases:
- Hyperfunction of pituitary gland
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2852 | 1930 | 912 |
| Only index persons | 2430 | 1642 | 788 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.03 |
| Only index persons | 0.05 | 0.06 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 9.59 | 8.54 | 11.31 |
| Only index persons | 9.31 | 8.52 | 10.97 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 219 | 151 | 68 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.03 |
| Median age at first event (years) | 10.34 | 8.94 | 13.45 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 240
- Matched controls
- 2400
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L02AE02
ATC
leuprorelin; implant, parenteral
79.0
117.3
64
11
E22.80
ICD-10 Finland
Central precocious puberty
+∞
111.3
98
*
2594A
ICD-9 Finland
Other endocrine disorders, Dwarfism, not elsewhere classified
+∞
50.9
47
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
18.5
50.7
43
28
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
38.6
36
*
H01AC01
ATC
somatropin; parenteral
+∞
36.4
34
*
E30.1
ICD-10 Finland
Precocious puberty
+∞
36.4
34
*
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
+∞
32.0
30
*
H02AB09
ATC
hydrocortisone; systemic
11.2
25.2
28
28
2591A
ICD-9 Finland
Other endocrine disorders, Precocious sexual development and puberty, not elsewhere classified
+∞
22.2
21
*
E22.88
ICD-10 Finland
Other hyperfunction of pituitary gland
+∞
21.2
20
*
2590A
ICD-9 Finland
Other endocrine disorders, Delay in sexual development and puberty, not elsewhere classified
+∞
20.1
19
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
+∞
17.9
17
*
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
16.9
16
*
L02AE04
ATC
triptorelin; parenteral
+∞
14.7
14
*
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
159.3
14.6
15
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.6
14.0
36
88
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
79.8
13.7
15
*
2599X
ICD-9 Finland
Other endocrine disorders, Unspecified endocrine disorder
+∞
13.7
13
*
E22.1
ICD-10 Finland
Hyperprolactinaemia
+∞
12.6
12
*
7834C
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]
+∞
12.6
12
*
2592A
ICD-9 Finland
Other endocrine disorders, Carcinoid syndrome
+∞
12.6
12
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
125.8
11.5
12
*
102
Kela drug reimbursment
Diabetes insipidus
+∞
10.5
10
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
10.3
85
423
H47.2
ICD-10 Finland
Optic atrophy
41.9
10.1
12
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.7
10.0
34
102
E34.35
ICD-10 Finland
Abnormal growth retardation
57.4
9.7
11
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
9.6
71
334
301
Kela drug reimbursment
Growth hormone
+∞
9.4
9
*
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
+∞
9.4
9
*
2598X
ICD-9 Finland
Other endocrine disorders, Other specified endocrine disorders
+∞
9.4
9
*
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
5.3
9.3
19
38
E34.31
ICD-10 Finland
Short stature, prenatal disorder
93.2
8.5
9
*
F83
ICD-10 Finland
Mixed specific developmental disorders
10.6
8.2
15
15
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
8.1
81
434
F82
ICD-10 Finland
Specific developmental disorder of motor function
9.3
7.7
15
17
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
14.0
7.5
12
9
E30.9
ICD-10 Finland
Disorder of puberty, unspecified
+∞
7.3
7
*
E30.8
ICD-10 Finland
Other disorders of puberty
+∞
7.3
7
*
E22.8
ICD-10 Finland
Other hyperfunction of pituitary gland
+∞
7.3
7
*
E34.30
ICD-10 Finland
Short stature NOS
+∞
7.3
7
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
7.0
7.3
17
26
L04AA01
ATC
[U] ciclosporin
20.8
7.2
10
5
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.4
7.1
18
43
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.4
7.1
26
82
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
41.2
6.8
8
*
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
23.3
6.7
9
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
6.7
19
50
G03DB01
ATC
dydrogesterone; oral
3.1
6.5
29
103
G81.1
ICD-10 Finland
Spastic hemiplegia
71.7
6.5
7
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
6.4
47
218
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
6.3
42
185
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
6.3
53
260
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
6.3
47
219
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
+∞
6.3
6
*
E34.45
ICD-10 Finland
Abnormal growth increase
+∞
6.3
6
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
6.3
6
*
P85
ICPC
Mental retardation
27.5
6.3
8
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
27.5
6.3
8
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.5
6.2
22
68
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.7
6.0
35
144
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
52
99
6.43
27.48
3.6
1.4
6.47
7.76
u/l
0.45
47
77
46
110
4.94
18.61
3.6
1.4
9.40
13.30
iu/l
0.62
39
83
105
607
2.30
8.89
9.6
6.4
1.21
1.22
mmol/l
0.20
94
568
111
690
2.13
7.54
11.1
6.5
1.21
1.22
mmol/l
0.36
98
606
87
497
2.18
7.30
5.2
6.9
1.06
1.13
inr
0.76
29
171
35
149
2.58
5.64
7.7
8.7
25.18
24.96
mmol/l
0.16
35
149
210
1767
2.51
5.47
17.6
8.7
3.90
3.89
mmol/l
0.06
203
1697
210
1767
2.51
5.47
17.8
8.7
139.57
139.45
mmol/l
0.27
203
1708
5
0
+∞
5.22
2.0
0.0
—
—
—
0
0
130
948
1.81
4.84
6.4
4.2
6.15
6.29
mmol/l
0.37
121
834
104
724
1.77
4.42
7.0
4.9
9.62
10.24
umol/l
0.37
98
670
80
520
1.81
4.26
5.2
3.1
—
—
—
0
0
7
7
10.25
4.03
5.7
1.0
2.87
2.04
nmol/l
—
7
7
38
195
2.13
4.01
2.1
1.7
—
—
—
0
0
36
181
2.16
3.99
5.5
6.5
5.86
5.68
kpa
0.73
36
176
70
446
1.80
3.94
3.0
2.3
2.37
2.35
mmol/l
0.52
63
404
141
1094
1.70
3.89
12.5
7.9
4.44
3.86
e9/l
1.99
127
962
70
452
1.77
3.75
2.6
2.3
48.44
58.05
u/l
2.02
63
419
183
1543
1.78
3.57
11.9
7.0
105.28
100.06
ml/min/173m2
2.22
140
1160
6
6
10.21
3.51
1.3
1.5
—
—
—
0
0
28
135
2.22
3.44
1.9
1.5
—
—
—
0
0
28
136
2.20
3.38
15.9
7.3
8.15
6.17
mmol/l
1.03
28
131
80
552
1.67
3.33
7.2
4.7
36.32
37.85
g/l
1.78
71
521
147
1182
1.63
3.30
8.5
5.4
81.90
78.53
u/l
0.33
138
1118
99
724
1.63
3.27
3.6
2.4
70.45
71.29
nmol/l
0.11
92
667
8
15
5.48
3.22
2.1
1.5
—
—
—
0
0
65
433
1.69
3.06
4.6
2.9
0.49
0.25
e6/l
0.42
51
322
27
135
2.13
3.05
2.0
1.6
—
—
—
0
0
35
193
1.95
3.04
2.8
3.4
587.97
897.99
ng/l
0.50
29
151
10
26
3.97
3.01
1.3
1.2
—
—
—
0
0
5
5
10.17
2.99
2.4
2.8
—
—
—
0
0
23
109
2.23
2.96
3.1
2.6
—
—
—
0
0
11
32
3.55
2.94
4.8
2.3
24.45
23.87
mmol/l
0.18
11
32
26
132
2.09
2.83
6.2
6.9
23.96
23.35
mmol/l
0.60
26
132
13
50
2.69
2.57
13.2
11.1
24.08
23.57
mmol/l
0.21
13
50
18
82
2.29
2.54
1.8
1.4
—
—
—
0
0
25
131
2.01
2.52
9.2
8.3
106.16
105.24
mmol/l
0.31
25
131
8
21
3.90
2.48
1.6
1.6
—
—
—
0
0
39
240
1.75
2.42
2.8
2.8
7.93
3.67
e6/l
0.93
23
123
10
34
3.02
2.31
1.9
1.6
—
—
—
0
0
172
1495
1.53
2.29
5.6
3.8
14.38
14.39
pmol/l
0.02
161
1369
40
252
1.70
2.29
2.6
2.7
1.30
0.75
e6/l
0.56
23
135
9
29
3.18
2.25
2.0
1.5
—
—
—
0
0
60
423
1.56
2.20
3.8
2.5
11.83
30.85
ng/l
1.34
35
180
10
37
2.78
2.09
2.5
1.5
—
—
—
0
0
7
20
3.57
2.07
1.0
1.3
—
—
—
0
0
6
16
3.82
1.94
2.3
1.9
—
—
—
0
0
6
16
3.82
1.94
2.3
1.9
—
—
—
0
0
55
393
1.52
1.89
4.6
2.2
—
—
—
0
0
5
12
4.23
1.83
2.4
1.3
1.92
1.56
mmol/l
—
5
12
103
839
1.40
1.77
4.1
2.4
—
—
—
0
0
7
24
2.97
1.73
2.1
1.8
—
—
—
0
0
7
24
2.97
1.73
2.1
1.8
—
—
—
0
0
209
1935
1.62
1.73
12.1
7.3
28.05
26.90
u/l
0.34
204
1869
76
592
1.42
1.67
4.4
2.8
54.27
30.30
u/l
0.74
71
552
24
145
1.73
1.61
10.4
4.7
1.11
1.17
mmol/l
0.04
19
103
8
33
2.47
1.55
4.0
4.1
51.63
55.73
%
—
8
33
24
147
1.70
1.54
10.8
4.7
5.11
4.96
kpa
0.49
24
140
171
1535
1.40
1.54
3.6
2.9
5.57
5.56
mmol/l
0.04
158
1406
7
155
0.44
1.48
1.7
1.7
—
—
—
0
0
15
80
1.93
1.48
2.6
1.5
—
—
—
0
0
51
377
1.45
1.48
1.9
1.5
1.57
1.31
mmol/l
1.23
46
329
7
28
2.54
1.46
2.1
2.4
—
—
—
0
0
5
16
3.17
1.44
3.2
2.9
—
—
—
0
0
5
16
3.17
1.44
2.0
1.2
—
—
—
0
0
38
266
1.51
1.44
4.3
4.5
3.12
16.82
mg/mmol
2.49
25
182
16
89
1.85
1.41
1.5
1.4
—
—
—
0
0
16
89
1.85
1.41
2.2
5.3
100.81
96.29
%
0.37
16
89
12
60
2.05
1.40
2.1
2.2
0.31
0.09
e6/l
0.56
12
55
188
1731
1.40
1.32
5.9
4.3
1.66
1.74
mu/l
0.70
179
1622
8
34
2.40
1.30
1.1
1.3
—
—
—
0
0
8
34
2.40
1.30
1.1
1.3
—
—
—
0
0
13
70
1.91
1.26
1.5
1.6
—
—
—
0
0
166
1505
1.33
1.25
3.4
2.8
1.33
1.18
mmol/l
2.02
159
1417
5
19
2.66
1.22
5.2
3.1
—
—
—
0
0
5
19
2.66
1.22
5.2
3.3
6.00
10.16
%
—
5
19
11
57
1.97
1.19
1.5
1.7
—
—
—
0
0
148
1330
1.29
1.14
4.7
3.7
37.67
37.46
mmol/mol
0.07
143
1252
7
30
2.37
1.13
1.3
1.4
—
—
—
0
0
55
432
1.35
1.13
1.5
1.4
—
—
—
0
0
5
21
2.41
1.09
7.4
14.2
1092.80
767.71
nmol/l
—
5
21
5
21
2.41
1.09
11.4
20.8
1955.40
1355.00
nmol/l
—
5
21
5
21
2.41
1.09
1.8
1.5
—
—
—
0
0
5
21
2.41
1.09
2.0
1.2
—
—
—
0
0
140
1257
1.27
1.05
4.4
3.0
35.50
32.56
u/l
0.29
129
1207
142
1285
1.26
0.96
5.0
3.5
9.40
7.73
mm/h
1.15
132
1201
39
298
1.37
0.96
1.2
1.3
60.45
19.67
iu/ml
0.45
13
85
11
62
1.81
0.96
15.5
10.6
0.68
0.70
%
0.04
11
62
7
37
1.92
0.95
1.7
1.5
—
—
—
0
0
16
102
1.61
0.93
12.1
4.7
10.08
9.78
kpa
0.29
16
97
229
2219
1.70
0.92
23.2
13.6
272.98
261.58
e9/l
1.77
222
2168
12
71
1.73
0.90
2.3
5.5
3.08
3.25
g/l
0.21
12
66
18
120
1.54
0.88
3.4
3.1
26.42
31.86
%
1.15
12
88
6
30
2.02
0.87
1.7
1.4
—
—
—
0
0
229
2222
1.67
0.87
23.4
13.5
4.57
4.59
e12/l
0.13
222
2165
64
755
0.79
0.84
2.3
1.9
—
—
—
0
0
170
1583
1.25
0.83
3.7
3.0
1.42
1.45
mmol/l
0.42
164
1494
13
81
1.64
0.83
29.7
11.0
1.16
1.05
mg/l
0.39
13
75
171
1595
1.25
0.82
3.8
3.2
2.79
2.81
mmol/l
0.11
164
1500
19
131
1.49
0.81
4.8
4.6
—
—
—
0
0
60
501
1.26
0.80
1.7
1.5
98.74
98.03
pmol/l
0.04
29
256
170
1591
1.23
0.75
3.8
3.1
4.62
4.62
mmol/l
0.03
164
1508
228
2219
1.55
0.72
23.9
13.6
40.06
40.46
%
0.51
217
2121
26
196
1.37
0.71
1.1
1.3
147.50
166.32
iu/ml
—
7
78
5
26
1.94
0.71
1.0
1.0
—
—
—
0
0
203
1945
1.28
0.68
17.1
9.0
22.61
20.48
mg/l
0.39
169
1413
7
43
1.65
0.67
1.3
1.1
—
—
—
0
0
47
390
1.26
0.66
1.7
2.3
4.55
1.05
mg/l
0.55
30
275
10
62
1.64
0.66
16.8
10.6
1.00
1.27
%
—
10
62
56
478
1.22
0.62
4.7
3.2
0.00
0.01
estimate
0.80
18
186
8
50
1.62
0.62
1.0
1.1
—
—
—
0
0
31
247
1.29
0.60
2.0
2.3
6482.21
4493.39
u/l
—
8
107
18
132
1.39
0.59
1.1
1.4
217.56
281.43
miu/ml
—
9
67
99
896
1.18
0.58
4.6
3.0
0.00
0.00
estimate
-0.00
21
189
100
906
1.18
0.58
4.5
3.1
0.00
0.00
estimate
-0.00
20
178
6
35
1.73
0.58
5.2
1.8
136.00
134.20
g/l
—
6
25
8
54
1.50
0.58
1.8
1.9
—
—
—
0
0
17
228
0.73
0.58
1.2
1.5
—
—
—
0
0
6
36
1.68
0.57
1.0
1.3
—
—
—
0
0
24
187
1.31
0.55
2.5
1.9
—
—
—
0
0
28
346
0.78
0.54
1.4
1.5
—
—
—
0
0
50
439
1.18
0.42
3.0
2.2
2.72
2.63
mg/l
0.13
43
379
0
15
0.00
0.41
0.0
1.0
—
1.46
—
0
10
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
106.06
—
0
17
10
137
0.72
0.40
1.1
1.5
—
—
—
0
0
96
892
1.13
0.37
6.6
4.3
0.00
0.00
estimate
-0.00
18
186
13
168
0.76
0.37
1.3
1.3
—
—
—
0
0
9
71
1.28
0.36
1.4
1.7
—
—
—
0
0
15
117
1.30
0.36
1.4
1.2
—
32.81
—
0
7
76
698
1.13
0.35
4.9
3.0
—
—
—
0
0
28
238
1.20
0.34
2.7
2.5
1984.60
526.46
ng/l
0.60
15
107
14
173
0.80
0.29
1.4
1.6
—
—
—
0
0
16
194
0.81
0.29
1.4
1.5
—
—
—
0
0
11
85
1.31
0.28
1.5
1.3
—
—
—
0
0
71
659
1.11
0.27
1.5
1.5
0.62
2.23
u/ml
1.35
13
155
9
74
1.22
0.25
2.0
1.5
1.21
1.21
g/l
—
9
69
11
87
1.28
0.24
1.4
1.2
—
—
—
0
0
106
1011
1.09
0.23
4.5
2.7
93.01
63.07
ug/l
0.88
96
945
5
40
1.26
0.22
2.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
4.1
—
128.70
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
33
299
1.12
0.20
1.2
1.2
3.00
7.75
u/ml
0.96
12
132
6
52
1.16
0.19
2.7
1.8
—
—
—
0
0
6
53
1.14
0.19
1.3
1.1
—
—
—
0
0
7
62
1.13
0.17
1.4
2.0
—
—
—
0
0
9
81
1.12
0.15
1.1
1.4
—
—
—
0
0
21
232
0.90
0.14
1.2
1.4
—
—
—
0
0
9
105
0.85
0.13
1.3
1.4
—
—
—
0
0
5
47
1.07
0.09
1.4
1.1
—
—
—
0
0
5
47
1.07
0.09
1.4
1.1
—
—
—
0
0
62
642
0.95
0.09
2.3
2.2
—
—
—
0
0
6
54
1.11
0.09
2.3
2.0
—
—
—
0
0
6
70
0.85
0.07
1.5
1.3
—
—
—
0
0
185
1866
0.96
0.06
4.7
4.0
—
—
—
0
0
44
453
0.96
0.04
2.6
2.0
—
—
—
0
0
39
378
1.04
0.04
1.8
1.9
—
—
—
0
0
10
92
1.09
0.03
1.5
1.7
—
—
—
0
0
71
699
1.02
0.03
2.6
2.4
—
—
—
0
0
17
176
0.96
0.00
1.3
1.4
—
—
—
0
0
17
176
0.96
0.00
1.3
1.4
—
—
—
0
0
13
128
1.02
0.00
2.1
2.0
—
—
—
0
0
17
175
0.97
0.00
1.2
1.4
—
—
—
0
0
17
175
0.97
0.00
1.2
1.4
—
—
—
0
0
19
185
1.03
0.00
1.1
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
5
51
0.98
0.00
1.0
1.2
—
13.71
—
0
7
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
301.95
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint E4_PRECOXCENTPUB and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have E4_PRECOXCENTPUB.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: E4_PRECOXCENTPUB – Precocious central puberty
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data